查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1877388

個人化醫療奈米材料市場：按應用領域、終端用戶、奈米材料類型、所用技術和地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Nanomaterials In Personalized Medicine Market, By Application Areas, By End-users, By Type of Nanomaterials, By Technology Utilized, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 375 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年個人化醫療奈米材料市場規模為 3554.5634 億美元，從 2025 年到 2032 年以 11.5% 的複合年成長率成長。

個人化醫療中的奈米材料是指能夠以精確可控的方式與生物系統相互作用的奈米級工程物質，它能夠根據個體的特定基因、分子或生理特徵量身定做醫療干預措施。慢性病盛行率的上升和奈米技術的進步是推動奈米材料應用的主要動力，但高昂的研發成本和監管障礙是重要的阻礙因素。然而，開發具有更優異性能的新型奈米材料、利用人工智慧進行藥物研發以及拓展新興市場都蘊藏著巨大的機會。製藥公司、生技公司和學術機構之間的策略合作對於克服這些障礙、實現市場潛力至關重要。

個人化醫療中的奈米材料市場－市場動態

個人化醫療需求不斷成長推動市場發展

未來幾年，個人化醫療需求的不斷成長預計將推動奈米材料在個人化醫療市場的發展。個人化醫療是一種醫療方法，它根據患者的遺傳、環境和生活方式因素，量身定做治療方案，以最佳化治療效果並改善護理。隨著基因組技術的進步，精準識別基因變異並為個體制定個人化治療方案成為可能，個人化醫療的需求也日益成長。奈米材料透過實現標靶和患者特異性治療，提升了個人化醫療的療效和安全性。它們能夠實現藥物、基因或RNA的標靶遞送，從而降低副作用並改善治療效果。據總部位於美國的非營利組織個人化醫療聯盟（PMC）稱，美國食品藥物管理局（FDA）在2023年批准了26種新的個人化藥物，高於2022年的12種。因此，對個人化醫療日益成長的需求正在推動個人化醫療產業中奈米材料的發展。

個人化醫療奈米材料市場細分分析：

全球市場按應用領域、最終用戶、奈米材料類型、所用技術、配方類型和地區進行細分。

製劑種類主要分為奈米顆粒、奈米晶體、奈米懸浮液、奈米乳劑和標靶遞送奈米製劑。其中，奈米顆粒是奈米材料市場中個人化醫療的關鍵組成部分，在標靶藥物遞送、癌症治療和診斷方面發揮著至關重要的作用。它們能夠克服生物屏障，並將治療藥物精準地遞送至病變細胞，使其成為各種醫療應用的理想選擇。例如，2025年4月，Marama Labs推出了CloudSpec，這是一款能夠加速脂質奈米顆粒中藥物有效載荷定量分析的儀器，可在15秒內完成RNA或DNA的精確測量。

從應用領域來看，藥物遞送系統是奈米材料在個人化醫療市場中最重要的細分領域之一，因為奈米載體（尤其是脂質奈米顆粒，即LNP）能夠將包括mRNA、siRNA和基因編輯劑在內的個人化療法精準、安全、高效地遞送至目標細胞，同時保護脆弱的核酸並最大限度地減少脫靶效應。 Acuitas Therapeutics就是一個引人注目的例子，該公司是LNP遞送技術的先驅。在2025年的ASGCT年會上，Acuitas展示了下一代LNP的臨床前資料，該LNP採用DARPin偶聯配體，可將mRNA有效載荷定向遞送至T細胞，並驗證了重複給藥的安全性以及肝臟以外的靶向性。 2024年5月，Aldevron宣布與Acuitas建立策略夥伴關係，部署其LNP平台進行mRNA從序列到製劑的生產，從而顯著提高個人化RNA療法的產能。

個人化醫療奈米材料市場—地域性洞察

亞太地區在個人化醫療奈米材料市場佔據顯著佔有率，這得益於政府的大力支持、不斷完善的生物技術基礎設施以及醫療保健投資的增加。中國、印度、日本和韓國等國家處於領先地位，其國家級計畫大力支持奈米技術研究和精準醫療的發展。疾病盛行率的上升，尤其是慢性病和遺傳性疾病，推動了對個人化奈米藥物的需求成長。該地區不斷壯大的中產階級，以及先進醫療保健服務的普及，促進了奈米技術在診斷和治療領域的應用。亞太地區正迅速成為創新和成長的關鍵市場，研發和商業化能力都在快速擴張。

日本奈米材料在個人化醫療市場的應用—國家概況

由於政府大力支持研發以及完善的生物技術基礎設施，日本正崛起為奈米醫學創新的重要中心。日本奈米醫學學會鼓勵學術界、產業界和醫療機構合作，以推動基於奈米材料的個人化醫療療法。 2024年4月，芬蘭奈米製藥公司Nanoform與日本製藥公司CBC株式會社達成策略合作，將Nanoform的奈米顆粒工程平台引進日本。此舉旨在提高藥物的生物利用度，並降低日本患者的用藥劑量。此外，位於川崎的奈米醫學創新中心（iCONM）正引領著前沿研究：2025年中期，一個研究團隊開發出一種奈米藥物，可將反義核酸遞送至淋巴結，進而抑制癌症轉移。

個人化醫療奈米材料市場競爭格局：

個人化醫療奈米材料市場的競爭格局集中度適中，主要參與者包括贏創工業集團（Evonik Industries AG）、OncoNano Medicine Inc. 和默克集團（Merck KGaA）。贏創致力於開發用於癌症治療的脂質奈米載體，而OncoNano Medicine則專注於用於精準藥物遞送和成像的金奈米顆粒平台。默克集團則利用聚合物基奈米材料進行標靶基因治療和個人化預防。這些公司競相提升奈米載體的生物相容性、穩定性和標靶能力。策略合作、臨床協作和規模化生產計畫均有助於推動創新。隨著對客製化治療的需求不斷成長，各公司優先考慮研發投入和商業化策略，以保持其在精準奈米醫學領域的領先地位。

目錄

第1章：個人化醫療中的奈米材料市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
    • 奈米材料在個人化醫療市場的應用領域概覽
    • 個人化醫療奈米材料市場概覽（按終端用戶分類）
    • 個人化醫療中的奈米材料市場概覽（按奈米材料類型分類）
    • 個人化醫療中的奈米材料市場概覽（按所用技術分類）
    • 個人化醫療奈米材料市場概覽（按製劑類型分類）
    • 奈米材料在個人化醫療市場的應用（按國家/地區分類）
    • 個人化醫療奈米材料市場概覽（按地區分類）
  • 競爭洞察

第3章：奈米材料在個人化醫療中的應用－關鍵市場趨勢

  • 個人化醫療中的奈米材料市場促進因素
    • 市場促進因素的影響分析
  • 奈米材料在個人化醫療市場中的限制因素
    • 市場限制因素的影響分析
  • 奈米材料在個人化醫療中的市場機遇
  • 奈米材料在個人化醫療市場的未來趨勢

第4章：奈米材料在個人化醫療產業的應用研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：個人化醫療市場中的奈米材料：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：奈米材料在個人化醫療市場的應用概況

  • 2024年個人化醫療奈米材料市場佔有率分析
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：奈米材料在個人化醫療市場的應用－依應用領域分類

  • 概述
    • 按應用領域分類的細分市場佔有率分析
    • 藥物輸送系統
    • 再生醫學
    • 診斷和影像
    • 療法
    • 疫苗

第8章：奈米材料在個人化醫療市場的應用－以終端使用者分類

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 生技公司
    • 學術機構
    • 研究實驗室
    • 製藥公司

第9章：個人化醫療市場中的奈米材料－以奈米材料類型分類

  • 概述
    • 按奈米材料類型分類的細分市場佔有率分析
    • 碳基奈米材料
    • 奈米結構材料
    • 金屬奈米粒子
    • 聚合物奈米材料
    • 二氧化矽奈米顆粒

第10章：個人化醫療市場中的奈米材料－依所採用的技術分類

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 奈米加工技術
    • 分子影像技術
    • 基於奈米技術的篩選方法
    • 生物偶聯方法
    • 表面改質技術

第11章：個人化醫療市場中的奈米材料－以製劑類型分類

  • 概述
    • 按配方類型分類的細分市場佔有率分析
    • 奈米顆粒
    • 奈米晶體
    • 奈米懸浮液
    • 奈米乳液
    • 用於標靶遞送的奈米製劑

第12章：個人化醫療市場中的奈米材料－依地域分類

  • 介紹
    • 按地域分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美個人化醫療奈米材料主要生產商
    • 北美市場規模及預測（按國家/地區分類）
    • 北美市場規模及預測（按應用領域分類）
    • 北美市場規模及預測（依最終用戶分類）
    • 北美奈米材料市場規模及預測（按奈米材料類型分類）
    • 北美市場規模及預測（依所用技術分類）
    • 北美市場規模及預測（依製劑類型分類）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲個人化醫療奈米材料主要生產商
    • 歐洲市場規模及預測（按國家/地區分類）
    • 歐洲市場規模及預測（按應用領域分類）
    • 歐洲市場規模及預測（依最終用戶分類）
    • 歐洲奈米材料市場規模及預測（按奈米材料類型分類）
    • 歐洲市場規模及預測（依所用技術分類）
    • 歐洲市場規模及預測（依製劑類型分類）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區
    • 概述
    • 亞太地區個人化醫療奈米材料主要生產商
    • 亞太市場規模及預測（依國家/地區分類）
    • 亞太地區市場規模及預測（依應用領域分類）
    • 亞太市場規模及預測（依最終用戶分類）
    • 亞太地區奈米材料市場規模及預測（依奈米材料類型分類）
    • 亞太地區市場規模及預測（依所用技術分類）
    • 亞太地區市場規模及預測（依製劑類型分類）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太其他地區
  • 拉丁美洲
    • 概述
    • 個人化醫療中的奈米材料：拉丁美洲主要生產商
    • 拉丁美洲市場規模及預測（按國家/地區分類）
    • 拉丁美洲市場規模及預測（按應用領域分類）
    • 拉丁美洲市場規模及預測（按最終用戶分類）
    • 拉丁美洲奈米材料市場規模及預測（按奈米材料類型分類）
    • 拉丁美洲市場規模及預測（依所用技術分類）
    • 拉丁美洲市場規模及預測，依製劑類型分類
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 個人化醫療中的奈米材料：中東和非洲的主要生產商
    • 中東和非洲市場規模及預測（按國家/地區分類）
    • 中東和非洲市場規模及預測（按應用領域分類）
    • 中東和非洲市場規模及預測（按最終用戶分類）
    • 中東和非洲奈米材料市場規模及預測（按奈米材料類型分類）
    • 中東和非洲市場規模及預測（按所用技術分類）
    • 中東和非洲市場規模及預測（按製劑類型分類）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 中東和非洲其他地區

第13章：關鍵供應商分析－個人化醫療產業的奈米材料

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • Merck KGaA Darmstadt Germany
    • OncoNano Medicine Inc.
    • Molecular Rebar Design Inc
    • Cello Therapeutics Inc.
    • Evonik Industries AG
    • Eisai Co. Ltd.
    • TUV Rheinland AG
    • OCSiAl SA
    • Sanofi SA
    • The Bristol-Myers Squibb Company
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • American Elements Inc.
    • Pfizer & Co. Inc
    • BASF SE
    • Cour Pharmaceuticals Inc.
    • Nanocomposix Inc
    • NoPo Nanotechnologies Private Limited
    • Matexcel Biotech Inc.
    • Apurano Pharmaceuticals GmbH
    • SGN Nanopharma Inc.
    • Others

第14章：360度分析師視角

第15章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5747

The Nanomaterials In Personalized Medicine Market size was valued at US$ 355,456.34 Million in 2024, expanding at a CAGR of 11.5% from 2025 to 2032.

Nanomaterials in personalized medicine are nanoscale-engineered substances that interact with biological systems in a precise and controlled manner, allowing healthcare interventions to be tailored to an individual's specific genetic, molecular, or physiological characteristics. The rising prevalence of chronic diseases and advances in nanotechnology are major motivators, but high development costs and regulatory hurdles are significant impediments. However, opportunities exist for the development of novel nanomaterials with improved properties, the use of AI in drug discovery, and expansion into emerging markets. Strategic collaborations between pharmaceutical companies, biotechnology firms, and academic institutions are critical for overcoming these obstacles and realizing market potential.

Nanomaterials In Personalized Medicine Market- Market Dynamics

Increasing Demand for Personalized Medicine Fueling the Market Growth

The rising demand for personalized medicine is expected to drive the growth of nanomaterials in the personalized medicine market in the coming years. Personalized medicine is a medical approach in which treatments are tailored to individual patients based on genetic, environmental, and lifestyle factors in order to optimize outcomes and improve care. The demand for personalized medicine is growing as genomic technologies advance, allowing for the precise identification of genetic variations and tailored treatments for individuals. Nanomaterials improve personalized medicine by allowing for targeted and patient-specific therapies, which improves treatment efficacy and safety. They enable targeted delivery of drugs, genes, or RNA, lowering side effects and improving therapeutic outcomes. According to the Personalized Medicine Coalition (PMC), a nonprofit organization based in the United States, the FDA approved 26 new personalized medicines in 2023, up from 12 in 2022. As a result, the growing demand for personalized medicine is driving the development of nanomaterials in the personalized medicine industry.

Nanomaterials In Personalized Medicine Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Application Areas, End-users, Type of Nanomaterials, Technology Utilized, Formulation Type, and Region.

The Formulation Type segment is primarily categorized into Nanoparticles, Nanocrystals, Nanosuspensions, Nanoemulsions, and Nanoformulations for Targeted Delivery. Among which. Nanoparticles are a crucial segment in the nanomaterials market for personalized medicine, playing a vital role in targeted drug delivery, cancer treatment and diagnostics. Their ability to overcome biological barriers and deliver therapeutic agents precisely to diseased cells makes them an attractive solution for various medical applications. For instance, in April 2025, Marama Labs launched CloudSpec, an instrument that accelerates quantification of drug payloads in lipid nanoparticles, enabling precise RNA or DNA measurements within 15 seconds.

Based on Application Areas, Drug Delivery Systems are one of the most important segments of the Nanomaterials in Personalized Medicine market because nano-enabled carriers (particularly lipid nanoparticles, or LNPs) enable the precise, safe, and efficient delivery of personalized therapies-including mRNA, siRNA, and gene-editing agents-to the intended cells while protecting fragile nucleic acids and minimizing off-target effects. One compelling example is Acuitas Therapeutics, a pioneer in LNP delivery technology. At the ASGCT annual meeting in 2025, Acuitas presented preclinical data for next-generation LNPs with DARPin-conjugated ligands to direct mRNA payloads to T-cells, as well as repeat dosing safety and targeting beyond the liver. In May 2024, Aldevron announced a strategic partnership with Acuitas to deploy its LNP platform for mRNA sequence-to-vial manufacturing, significantly increasing capacity for personalized RNA therapies.

Nanomaterials In Personalized Medicine Market- Geographical Insights

Asia Pacific has a significant share of the Nanomaterials in personalized medicine Market, owing to strong government initiatives, expanding biotech infrastructure, and increased healthcare investment. Countries such as China, India, Japan, and South Korea are at the forefront, with national programs supporting nanotechnology research and precision medicine development. Rising disease prevalence, particularly in chronic and genetic conditions, drives up demand for personalized nanomedicines. The region's growing middle class, combined with improved access to advanced healthcare, promotes the use of nano-enabled diagnostics and therapeutics. Asia Pacific is becoming a key market for innovation and growth, with rapid expansion in R&D and commercial capacity.

Japan Nanomaterials In Personalized Medicine Market- Country Insights

Japan is emerging as a major hub for nanomedicine innovation, due to strong government R&D support and a well-established biotech infrastructure. The Japan Nanomedicine Society encourages collaboration among academia, industry, and healthcare to advance nanomaterial-based therapies for personalized medicine. In April 2024, Nanoform Finland formed a strategic partnership with Japanese pharmaceutical firm CBC Co., Ltd. to bring Nanoform's nanoparticle-engineering platform to Japan. The goal is to improve drug bioavailability and reduce doses for Japanese patients. Furthermore, the Innovation Center of NanoMedicine (iCONM) in Kawasaki is spearheading cutting-edge research: in mid-2025, a team of researchers developed a nanomedicine that delivers antisense nucleic acids to lymph nodes to suppress cancer metastases.

Nanomaterials In Personalized Medicine Market- Competitive Landscape:

The competitive landscape for Nanomaterials in Personalized Medicine Market is moderately concentrated, with major players including Evonik Industries AG, OncoNano Medicine Inc., and Merck KGaA. Evonik is developing lipid-based nanocarriers for cancer treatments, whereas OncoNano Medicine focuses on gold nanoparticle platforms for precise drug delivery and imaging. Merck KGaA uses polymer-based nanomaterials for targeted gene therapy and personalized prophylactics. These companies compete to improve nanocarriers' biocompatibility, stability, and targeting capabilities. Strategic partnerships, clinical collaborations, and scale-up initiatives all contribute to innovation. As the demand for tailored treatments grows, companies prioritize R&D investment and commercialization strategies to maintain their position as leaders in precision nanomedicine.

Recent Developments:

In June 2023, Bayer AG, a German pharmaceutical and biotechnology company, has partnered with Acuitas Therapeutics Inc. to gain access to its lipid nanoparticle (LNP) delivery technology. This collaboration aims to advance Bayer's in vivo gene editing and protein replacement programs by utilizing Acuitas' lipid nanoparticle technology, which enables efficient and targeted RNA delivery, particularly to the liver. Acuitas Therapeutics Inc. is a Canadian biotechnology company that specializes in lipid nanoparticle (LNP) delivery systems, which are important nanomaterials for personalized medicine.

In September 2023, Evonik improved its parenteral drug delivery solutions with three new PLA-PEG di-block copolymers (RESOMER RP d) and a nanoparticle formulation service based on sonication technology. The copolymers are excellent for nanoparticle formation and controlled drug release applications. The new nanosonication process allows for cGMP production of nanoparticles, addressing production challenges in drug delivery.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Merck KGaA Darmstadt Germany
  • OncoNano Medicine Inc.
  • Molecular Rebar Design Inc
  • Cello Therapeutics Inc.
  • Evonik Industries AG
  • Eisai Co. Ltd.
  • TUV Rheinland AG
  • OCSiAl S.A
  • Sanofi S.A.
  • The Bristol-Myers Squibb Company
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • American Elements Inc.
  • Pfizer & Co. Inc
  • BASF SE
  • Cour Pharmaceuticals Inc.
  • Nanocomposix Inc
  • NoPo Nanotechnologies Private Limited
  • Matexcel Biotech Inc.
  • Apurano Pharmaceuticals GmbH
  • SGN Nanopharma Inc.
  • Others

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY APPLICATION AREAS- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery Systems
  • Regenerative Medicine
  • Diagnostics and Imaging
  • Therapeutics
  • Vaccines

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Biotechnology Firms
  • Academic Institutions
  • Research Laboratories
  • Pharmaceutical Companies

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TYPE OF NANOMATERIALS- MARKET ANALYSIS, 2019 - 2032

  • Carbon-based Nanomaterials
  • Nanostructured Materials
  • Metallic Nanoparticles
  • Polymeric Nanomaterials
  • Silica Nanoparticles

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TECHNOLOGY UTILIZED- MARKET ANALYSIS, 2019 - 2032

  • Nanofabrication Techniques
  • Molecular Imaging Techniques
  • Nanotechnology-based Screening Methods
  • Bioconjugation Methods
  • Surface Modification Techniques

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanoparticles
  • Nanocrystals
  • Nanosuspensions
  • Nanoemulsions
  • Nanoformulations for Targeted Delivery

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nanomaterials In Personalized Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nanomaterials In Personalized Medicine Market Snippet by Application Areas
    • 2.1.2. Nanomaterials In Personalized Medicine Market Snippet by End-users
    • 2.1.3. Nanomaterials In Personalized Medicine Market Snippet by Type of Nanomaterials
    • 2.1.4. Nanomaterials In Personalized Medicine Market Snippet by Technology Utilized
    • 2.1.5. Nanomaterials In Personalized Medicine Market Snippet by Formulation Type
    • 2.1.6. Nanomaterials In Personalized Medicine Market Snippet by Country
    • 2.1.7. Nanomaterials In Personalized Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Nanomaterials In Personalized Medicine Key Market Trends

  • 3.1. Nanomaterials In Personalized Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nanomaterials In Personalized Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nanomaterials In Personalized Medicine Market Opportunities
  • 3.4. Nanomaterials In Personalized Medicine Market Future Trends

4. Nanomaterials In Personalized Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nanomaterials In Personalized Medicine Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Nanomaterials In Personalized Medicine Market Landscape

  • 6.1. Nanomaterials In Personalized Medicine Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nanomaterials In Personalized Medicine Market - By Application Areas

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application Areas, 2024 & 2032 (%)
    • 7.1.2. Drug Delivery Systems
    • 7.1.3. Regenerative Medicine
    • 7.1.4. Diagnostics and Imaging
    • 7.1.5. Therapeutics
    • 7.1.6. Vaccines

8. Nanomaterials In Personalized Medicine Market - By End-users

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-users, 2024 & 2032 (%)
    • 8.1.2. Hospitals & Clinics
    • 8.1.3. Biotechnology Firms
    • 8.1.4. Academic Institutions
    • 8.1.5. Research Laboratories
    • 8.1.6. Pharmaceutical Companies

9. Nanomaterials In Personalized Medicine Market - By Type of Nanomaterials

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Type of Nanomaterials, 2024 & 2032 (%)
    • 9.1.2. Carbon-based Nanomaterials
    • 9.1.3. Nanostructured Materials
    • 9.1.4. Metallic Nanoparticles
    • 9.1.5. Polymeric Nanomaterials
    • 9.1.6. Silica Nanoparticles

10. Nanomaterials In Personalized Medicine Market - By Technology Utilized

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-users, 2024 & 2032 (%)
    • 10.1.2. Nanofabrication Techniques
    • 10.1.3. Molecular Imaging Techniques
    • 10.1.4. Nanotechnology-based Screening Methods
    • 10.1.5. Bioconjugation Methods
    • 10.1.6. Surface Modification Techniques

11. Nanomaterials In Personalized Medicine Market - By Formulation Type

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Formulation Type, 2024 & 2032 (%)
    • 11.1.2. Nanoparticles
    • 11.1.3. Nanocrystals
    • 11.1.4. Nanosuspensions
    • 11.1.5. Nanoemulsions
    • 11.1.6. Nanoformulations for Targeted Delivery

12. Nanomaterials In Personalized Medicine Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Nanomaterials In Personalized Medicine Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Nanomaterials In Personalized Medicine Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Nanomaterials In Personalized Medicine Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Nanomaterials In Personalized Medicine Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Nanomaterials In Personalized Medicine Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Nanomaterials In Personalized Medicine Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Merck KGaA Darmstadt Germany
    • 13.2.2. OncoNano Medicine Inc.
    • 13.2.3. Molecular Rebar Design Inc
    • 13.2.4. Cello Therapeutics Inc.
    • 13.2.5. Evonik Industries AG
    • 13.2.6. Eisai Co. Ltd.
    • 13.2.7. TUV Rheinland AG
    • 13.2.8. OCSiAl S.A
    • 13.2.9. Sanofi S.A.
    • 13.2.10. The Bristol-Myers Squibb Company
    • 13.2.11. Thermo Fisher Scientific Inc.
    • 13.2.12. Abbott Laboratories
    • 13.2.13. American Elements Inc.
    • 13.2.14. Pfizer & Co. Inc
    • 13.2.15. BASF SE
    • 13.2.16. Cour Pharmaceuticals Inc.
    • 13.2.17. Nanocomposix Inc
    • 13.2.18. NoPo Nanotechnologies Private Limited
    • 13.2.19. Matexcel Biotech Inc.
    • 13.2.20. Apurano Pharmaceuticals GmbH
    • 13.2.21. SGN Nanopharma Inc.
    • 13.2.22. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us